We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Cactus
WHD
$5.44B
| $2.29M | ﹤0.01% |
66,840
+4,934
| +8% | +$150K |
|
|
INST
1727
DELISTED
Instructure, Inc.
INST
| $2.29M | ﹤0.01% |
47,524
+2,411
| +5% | +$113K |
|
1728
Amkor Technology
AMKR
$13.6B
| $2.29M | ﹤0.01% |
176,094
+1,445
| +0.8% | +$17.2K |
|
1729
CBIZ
CBZ
$2.96B
| $2.29M | ﹤0.01% |
84,874
+1,432
| +2% | +$37.3K |
|
1730
Customers Bancorp
CUBI
$2.77B
| $2.29M | ﹤0.01% |
96,031
+4,063
| +4% | +$93.3K |
|
1731
Red Rock Resorts
RRR
$3.63B
| $2.28M | ﹤0.01% |
95,242
+2,803
| +3% | +$62.3K |
|
|
SRDX
1732
DELISTED
Surmodics
SRDX
| $2.28M | ﹤0.01% |
54,999
+2,548
| +5% | +$107K |
|
|
MODV
1733
DELISTED
ModivCare
MODV
| $2.28M | ﹤0.01% |
38,501
+2,081
| +6% | +$127K |
|
|
VAL
1734
DELISTED
Valaris plc Class A Ordinary Share
VAL
| $2.27M | ﹤0.01% |
346,273
+30,733
| +10% | +$150K |
|
1735
Nelnet
NNI
$4.8B
| $2.27M | ﹤0.01% |
39,000
+544
| +1% | +$33.3K |
|
1736
Rush Enterprises Class A
RUSHA
$6.28B
| $2.27M | ﹤0.01% |
109,829
+1,829
| +2% | +$35.6K |
|
1737
Universal Electronics
UEIC
$59.5M
| $2.27M | ﹤0.01% |
43,412
+2,030
| +5% | +$109K |
|
|
SASR
1738
DELISTED
Sandy Spring Bancorp Inc
SASR
| $2.26M | ﹤0.01% |
59,702
+2,438
| +4% | +$86K |
|
1739
Champion Homes
SKY
$5.02B
| $2.25M | ﹤0.01% |
71,071
+5,372
| +8% | +$167K |
|
|
INFN
1740
DELISTED
Infinera Corporation Common Stock
INFN
| $2.25M | ﹤0.01% |
282,940
+14,128
| +5% | +$86.8K |
|
1741
United Parks & Resorts
PRKS
$2.1B
| $2.25M | ﹤0.01% |
70,784
+5,610
| +9% | +$162K |
|
1742
St. Joe Company
JOE
$3.79B
| $2.24M | ﹤0.01% |
113,128
+54,351
| +92% | +$1.01M |
|
1743
Brookdale Senior Living
BKD
$3.45B
| $2.24M | ﹤0.01% |
307,584
+4,779
| +2% | +$35.5K |
|
|
RARX
1744
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.23M | ﹤0.01% |
47,546
+6,749
| +17% | +$298K |
|
1745
Golar LNG
GLNG
$5.18B
| $2.22M | ﹤0.01% |
155,903
+6,699
| +4% | +$90.8K |
|
|
DCOM
1746
DELISTED
Dime Community Bancshares
DCOM
| $2.22M | ﹤0.01% |
106,107
+5,190
| +5% | +$106K |
|
1747
Verra Mobility
VRRM
$763M
| $2.21M | ﹤0.01% |
158,105
+15,876
| +11% | +$228K |
|
1748
Amphastar Pharmaceuticals
AMPH
$873M
| $2.21M | ﹤0.01% |
114,510
+5,579
| +5% | +$107K |
|
|
WLH
1749
DELISTED
WILLIAM LYON HOMES
WLH
| $2.2M | ﹤0.01% |
110,061
+4,920
| +5% | +$101K |
|
1750
Sinclair Inc
SBGI
$1.14B
| $2.2M | ﹤0.01% |
65,861
+615
| +0.9% | +$22.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.